Drug ID: | NPD604 |
Drug Name: | |
Molecular Formula: | C11H18N2O |
Canonical SMILES: | CC(NC(Cc1ccc(cn1)O)C)C |
Standard InCHI: | InChI=1S/C11H18N2O/c1-8(2)13-9(3)6-10-4-5-11(14)7-12-10/h4-5,7-9,13-14H,6H2,1-3H3 |
Standard InCHIKey: | WQRPBKUCJBWQRT-UHFFFAOYSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB010952 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 194.14 |
ALogP | -0.572 |
MLogP | 2.34 |
XLogP | 1.826 |
HDA | 2 |
HBD | 2 |
Rotatable Bonds | 8 |
TPSA | 45.15 |
RO5 Violation | 0 |